Autoimmune Encephalitis Series: A Rationale Approach to Diagnostics and Interpretation
In the second episode of a four-part series on autoimmune encephalitis, Dr. Justin Abbatemarco talks with Drs. Sarosh Irani and John Soltys about a practical approach to testing for auto antibodies an...
10 Elo 202322min
Autoimmune Encephalitis Series: Advancing the Science
In the first episode of a four-part series on autoimmune encephalitis, Dr. Justin Abbatemarco talks with Dr. Josep Dalmau about relevant updates on autoimmune encephalitis, ongoing/upcoming clinical t...
7 Elo 202323min
An Updated Round Table Discussion on FND: Diagnosis of FND and New Phenotypes
In this first episode of our three-part series, Prof. Jon Stone talks with Drs. Selma Aybek, David Perez, and Sarah Lidstone about FND diagnosis and exploring new phenotypes. Related Links: FND Socie...
3 Elo 202319min
August 2023 Neurology Recall: Functional Neurologic Disorders
The August 2023 replay of past episodes showcases four interviews on functional neurologic disorders with Prof. Jon Stone. The episode begins with an interview by Prof. Jon Stone and Dr. Tamara Prings...
2 Elo 20231h 29min
AAN President Elect Testified Before House Subcommittee on New Alzheimer Treatment
Dr. Stacey Clardy talks with Dr. Natalia Rost about her experience speaking before the House of Representatives on the approval of lecanemab for the treatment of early Alzheimer disease. Visit NPUb.or...
31 Heinä 202314min
Elamipretide for Mytochondrial Myopathy
Dr. Justin Abbatemarco talks with Dr. Amel Karaa about the use of elamipretide in participants with genetically confirmed primary mitochondrial myopathies. Read the related article in Neurology. Visi...
27 Heinä 202328min
Sarepta Announces FDA Approval of ELEVIDYS
Dr. Gordon Smith talks with Dr. Hoda Abdel-Hamid about the recent FDA approval for the first ever gene therapy for Duchenne muscular dystrophy. Visit NPUb.org/Podcast for associated article links.
24 Heinä 202320min
New Treatment for IDH mt Gliomas
Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas. Read the related arti...
20 Heinä 202318min
